Drugs / RPTR-147:2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03815682 | Oct 2018 → Sep 2022 | cancer, lymphoma | Repertoire Immune Medicines | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RPTR-147:2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03815682 ↗ |
| Modality | Cell therapy | “Deep IL-15 Loaded T-Cells” NCT03815682 ↗ |